Molecular Partners AG
MOLN
$4.34
$0.000.00%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | 0.00 |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | 0.00 |
| Cost of Revenue | 10.24M | 10.41M | 12.98M | 13.26M | 10.76M |
| Gross Profit | -10.24M | -10.41M | -12.98M | -13.26M | -10.76M |
| SG&A Expenses | 5.61M | 4.50M | 4.84M | 4.70M | 6.09M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.85M | 14.91M | 17.82M | 17.96M | 16.85M |
| Operating Income | -15.85M | -14.91M | -17.82M | -17.96M | -16.85M |
| Income Before Tax | -15.83M | -14.80M | -24.73M | -18.66M | -12.79M |
| Income Tax Expenses | 5.00K | -- | -- | -2.20K | 2.30K |
| Earnings from Continuing Operations | -15.83M | -14.80M | -24.73M | -18.66M | -12.79M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -15.83M | -14.80M | -24.73M | -18.66M | -12.79M |
| EBIT | -15.85M | -14.91M | -17.82M | -17.96M | -16.85M |
| EBITDA | -15.57M | -14.25M | -17.15M | -17.34M | -16.57M |
| EPS Basic | -0.42 | -0.40 | -0.66 | -0.51 | -0.35 |
| Normalized Basic EPS | -0.27 | -0.24 | -0.36 | -0.32 | -0.22 |
| EPS Diluted | -0.42 | -0.40 | -0.66 | -0.51 | -0.35 |
| Normalized Diluted EPS | -0.27 | -0.24 | -0.36 | -0.32 | -0.22 |
| Average Basic Shares Outstanding | 37.41M | 37.40M | 37.39M | 36.87M | 36.88M |
| Average Diluted Shares Outstanding | 37.41M | 37.40M | 37.39M | 36.87M | 36.88M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |